![Peter Kellogg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Kellogg
Director of Finance/CFO at RECEPTOS INC
Net worth: 312 333 $ as of 30/05/2025
Profile
Peter N.
Kellogg currently works at Alnylam Pharmaceuticals, Inc., as Independent Director from 2023, Idorsia Ltd., as Non-Executive Director from 2021, Idorsia Pharmaceuticals Ltd., as Director, and Receptos LLC, as Chief Financial Officer & Executive Vice President.
Mr. Kellogg also formerly worked at Yield10 Bioscience, Inc., as Independent Director from 2011 to 2020, Juno Therapeutics, Inc., as Director, Biogen MA, Inc., as Chief Financial Officer & Executive Vice President in 2003, Merck & Co., Inc., as Chief Financial Officer & Executive Vice President from 2007 to 2014, PepsiCo, Inc., as Senior Vice President-eCommerce in 2000, Schering-Plough Corp., as Chief Financial Officer & Executive Vice President in 2009, Biogen, Inc., as Chief Financial Officer & Executive Vice President from 2003 to 2007, Pepsi-Cola International Ltd. (New York), as Principal, Pepsi-Cola North America, as Principal, PepsiCo Food International, as Senior Vice President, Biogen Idec New Ventures, Inc., as Executive Vice President from 2000 to 2007, Biogen Idec, Inc. (North Carolina), as Chief Financial Officer & Executive VP-Finance from 2003 to 2007, Frito-Lay International, as Chief Financial Officer & Senior Vice President from 1998 to 2000, Merck Sharp & Dohme Corp., as Chief Financial Officer & Executive Vice President in 2009, and Celgene Corp., as Chief Corporate Strategy Officer & Executive VP from 2018 to 2019.
Mr. Kellogg received his undergraduate degree in 1978 from Princeton University and Masters Business Admin degree in 1982 from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 07/05/2025 | 775 ( 0% ) | 236 034 $ | 30/05/2025 | |
IDORSIA LTD. 0.02% | 30/12/2023 | 38,175 ( 0.02% ) | 76 299 $ | 30/05/2025 |
Latest news about Peter Kellogg
Peter Kellogg active positions
| Companies | Position | Start |
|---|---|---|
| RECEPTOS INC | Director of Finance/CFO | - |
| IDORSIA LTD | Director/Board Member | 11/05/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Director/Board Member | 06/03/2023 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Director/Board Member | - |
Former positions of Peter Kellogg
| Companies | Position | End |
|---|---|---|
| YIELD10 BIOSCIENCE, INC. | Director/Board Member | 10/02/2020 |
| CELGENE | Director of Finance/CFO | 31/07/2018 |
| MERCK & CO., INC. | Director of Finance/CFO | 22/04/2014 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Director of Finance/CFO | 02/11/2009 |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Director of Finance/CFO | 31/10/2009 |
Training of Peter Kellogg
Princeton University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| PEPSICO, INC. | Consumer Non-Durables |
| IDORSIA LTD | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 13 |
|---|---|
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
PepsiCo Food International
 PepsiCo Food International Beverages: Non-AlcoholicConsumer Non-Durables Part of PepsiCo, Inc., PepsiCo Food International is a carbonated beverage company. The company is based in Purchase, NY. | Consumer Non-Durables |
Frito-Lay International | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
Pepsi-Cola International Ltd. (New York)
 Pepsi-Cola International Ltd. (New York) Beverages: Non-AlcoholicConsumer Non-Durables Part of PepsiCo, Inc., Pepsi-Cola International Ltd. is a company based in Purchase, NY. The company makes soft drinks and snack foods. | Consumer Non-Durables |
Pepsi-Cola North America
 Pepsi-Cola North America Beverages: Non-AlcoholicConsumer Non-Durables Pepsi-Cola North America manufactures and markets beverage products. It offers soft drinks, bottled waters, iced teas, juices, and sports drinks. The company is headquartered in Purchase, NY | Consumer Non-Durables |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
- Stock Market
- Insiders
- Peter Kellogg
